Aberdeen Group plc

Holdings History for Quoin Pharmaceuticals, Ltd. - American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX)

Symbol: QNRX on Nasdaq
Investment type: Equity / American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share
Latest Disclosed Shares Owned: 75,000 shares
Security Ownership %: 8.9%

Shares, Excluding Options vs Price

Value, Excluding Options

Aberdeen Group plc ownership in Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX)

28 Jan 2026 - Aberdeen Group plc has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 75,000 shares of Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX). This represents 8.9% ownership of the company. This is the first filing by Aberdeen Group plc disclosing ownership of Quoin Pharmaceuticals, Ltd. American Depositary Shares, each representing thirty-five (35) Ordinary Shares, no par value per share (QNRX).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Aberdeen Group plc	8.9%		$1,082,250	75,000			$14.43	13G	31 Dec 2025	28 Jan 2026, 11:05

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0%	+0%	$1,082,250	75,000	+75,000	NEW	$14.43	Q4 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.